Skip to main content
Clinical Trials/NL-OMON35523
NL-OMON35523
Recruiting
Not Applicable

Clinical and molecular genetic aspects of idiopathic epilepsies - genetics of idiopathic epilepsies

Epilepsiecentrum Kempenhaeghe0 sites300 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
epilepsy
Sponsor
Epilepsiecentrum Kempenhaeghe
Enrollment
300
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Sponsor
Epilepsiecentrum Kempenhaeghe

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients with a familial history of epilepsy, with multiple (at least 4\) family members affected
  • 2\. Patients with a severe form of epilepsy with onset in the first year of life in which no acquired cause can be detected.
  • 3\. patients with a combination of epilepsy, mental retardation and dysmorphia (\=contiguous gene syndrome, probably caused by deletion/duplication of multiple genes and detectable by CGH)
  • 4\. Patients on a ketogenic diet with epilepsy of unknown origin
  • Theoretically there are no age restrictions. In case of severe epilepsy with early onset (cfr.2\), cases with neonatal onset will also be included, but as DNA diagnostics in a genetic research setting only will be done after all other possible causes are excluded, inclusion in this study in actual practice will only be done after 2 months of life.

Exclusion Criteria

  • Patients in which a acquired cause of epilepsy is suspected (for example perinatal brain damage, lesions visible on MRI,...)

Outcomes

Primary Outcomes

Not specified

Similar Trials